Lithium stocks rebound strongly as fears around Chile’s nationalization strategy recede

Last week, President Gabriel Boric of Chile announced the launch of the country’s new national lithium strategy to usher in the age of electrification and decarbonization, ensure environmental sustainability and ultimately, cement its position as the global leader in the production of silvery-white metal. Primarily, the policy seeks to nationalize Chilean reserves and manage this… Continue reading Lithium stocks rebound strongly as fears around Chile’s nationalization strategy recede

Liontrust share price at risk of a ~20% drop as it works to acquire GAM

Liontrust (LON: LIO) share price has been in a steep sell-off in the past few months as concerns about the asset manager continued. The shares plunged to a low of 828p on Thursday, which was ~36% below the highest point this year, meaning that it has moved to a bear market. Liontrust and GAM combination… Continue reading Liontrust share price at risk of a ~20% drop as it works to acquire GAM

Nifty 50 index vs S&P 500, Nasdaq 100: one clear winner in 2 decades

Which is the best-performing stock index in the world? Most people would cite American indices like the Nasdaq 100 and S&P 500 as the best performers. Sure, these indices have done well over the years. However, the Nifty 50 index has been the best-performing index in the past few decades by far. Nifty 50 index… Continue reading Nifty 50 index vs S&P 500, Nasdaq 100: one clear winner in 2 decades

Bed Bath & Beyond just filed for Chapter 11 bankruptcy

Bed Bath & Beyond Inc (NASDAQ: BBBY) just announced to have filed for Chapter 11 bankruptcy protection after none of its efforts in recent months raised capital needed to continue operations. Here’s what we know so far Sixth Street is lending roughly $240 million in “DIP” (debtor-in-possession financing) for the big box retailer to finance… Continue reading Bed Bath & Beyond just filed for Chapter 11 bankruptcy

BB Biotech reports a loss for the first three months of 2023

BB Biotech AG (SWX: BION) ended 3.0% down on Friday after reporting a loss for the first three months of 2023. BB Biotech’s loss narrowed year-on-year The investment firm that focuses exclusively on biotechnology says it lost CHF 254 million ($284.45 million) in the first quarter. In the same period last year, though, it had… Continue reading BB Biotech reports a loss for the first three months of 2023

Charles Schwab stock outlook: JPMorgan analyst sees 60% upside

U.S. banks have been under a lot of pressure lately but a JPMorgan analyst is still convinced that investing in Charles Schwab Corporation (NYSE: SCHW) at current levels positions you for lucrative returns. Charles Schwab stock could climb to $85 Kenneth Worthington reiterated the financial service company at “overweight” this week. His $85 price target… Continue reading Charles Schwab stock outlook: JPMorgan analyst sees 60% upside